Erratum to: Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China

Lin, Yu; Yang, Zhongping; Liang, Ying; Li, Zheng Tu; Bond, Helen S.; Chua, Huiying; Luo, Ya Sha; Chen, Yuan; Chen, Ting Ting; Guan, Wen Da; Lai, Jimmy C. C.; Siu, Yu Lam; Pan, Si Hua; Peiris, J S Malik; Cowling, Benjamin J.; Mok, Chris Ka Pun

doi:10.1186/s12879-017-2359-z

Search citation statements

Order By: Relevance

Paper Sections

Select...

Plos Pathogens1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 1 publication

(1 reference statement)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Finally, we investigated the impact of confirmed human H3 infection with or without documented receipt of the seasonal influenza vaccine on CIV neutralizing Ab (NAb) titers. Serum samples were obtained from patients enrolled at either the Johns Hopkins Health System (JHMI) or Chang Gung Memorial Hospital (CGMH) in Taipei, Taiwan with confirmed H3N2 infection and documentation of receipt of the seasonal influenza vaccine during the 2016-17 season (Fig 7) [36,37]. At baseline (i.e., at the time of enrollment), seroprotective NAbs (>1:40) against CIV-41915 were detected in 54% in contrast to 81% against human Beth15 H3N2 virus (Fig 7A).…”

Section: Plos Pathogensmentioning

confidence: 99%